Peter Briggs

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2019 2024

• 2 Active

Projects per year

A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination with Celecoxib and Gemcitabine in Patients with Malignant Pleural Mesothelioma

Briggs, P.

4/09/19 → 3/09/24

Project: Research

A Phase III, Double-Blind, Randomised Study to Assess the Efficacy and Safety of AZD9291 Versus a Standard of Care Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as First-Line Treatment In Patients with Epidermal Growth Factor Receptor Mutation Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer. (FLAURA Study)

Briggs, P.

26/02/19 → 25/02/24

Project: Research